Stereotactic Body Radiation Therapy for Curative Treatment of Adrenal Metastases
Authors:
Open Access
- 1 June 2013
- journal article
- research article
- Published by SAGE Publications in Technology in Cancer Research & Treatment
- Vol. 12 (3) , 217-224
Abstract
The detection of oligometastatic adrenal metastases is increasing and there are limited data supporting the use of curative intent stereotactic body radiation therapy (SBRT) to treat patients with limited metastatic disease with adrenal involvement. Therefore, we utilized a prospectively maintained database of consecutive patients treated with SBRT for limited metastatic disease (10 (43.2 Gy), corresponding to 24 Gy in 3 fractions. After treatment of adrenal metastases with SBRT, the median time to salvage chemotherapy was 5.3 months (range 1.0–38.8 months) and 1-year freedom from salvage chemotherapy was 44%. These results suggest that SBRT to adrenal metastases was tolerated with low toxicity in limited metastatic patients and control rates are promising. This study supports the growing body of literature treating patients with adrenal metastases with SBRT.Keywords
This publication has 18 references indexed in Scilit:
- Stereotactic body radiotherapy for multisite extracranial oligometastasesCancer, 2011
- Stereotactic Body Radiotherapy for Treatment of Adrenal MetastasesInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2009
- Adrenal Metastasis From Hepatocellular Carcinoma: Radiofrequency Ablation Combined With Adrenal Arterial Chemoembolization in Six PatientsAmerican Journal of Roentgenology, 2009
- Outcomes of Adrenalectomy for Isolated Synchronous Versus Metachronous Adrenal Metastases in Non–Small-Cell Lung Cancer: A Systematic Review and Pooled AnalysisJournal of Clinical Oncology, 2008
- A prospective pilot study of curative‐intent stereotactic body radiation therapy in patients with 5 or fewer oligometastatic lesionsCancer, 2007
- Actual 10-Year Survival After Resection of Colorectal Liver Metastases Defines CureJournal of Clinical Oncology, 2007
- Adrenal Masses in the Cancer Patient: Surveillance or ExcisionThe Oncologist, 2007
- Prognostic factors in patients who survived more than 10 years after undergoing surgery for metastatic brain tumorsSurgical Neurology, 2002
- Adrenalectomy for metastatic disease to the adrenal glandsBritish Journal of Surgery, 1996
- Metastases in carcinoma.Analysis of 1000 autopsied casesCancer, 1950